TY - JOUR
KW - Adult
KW - Age Factors
KW - buprenorphine
KW - Buprenorphine/economics/therapeutic use
KW - Comorbidity
KW - Counseling/economics/methods
KW - Delayed-Action Preparations
KW - Health Expenditures/statistics & numerical data
KW - Health Resources/economics/statistics & numerical data
KW - healthcare costs
KW - healthcare resource utilization
KW - Humans
KW - Male
KW - Methadone
KW - Methadone/economics/therapeutic use
KW - Middle Aged
KW - Models, Econometric
KW - Naltrexone
KW - Naltrexone/economics/therapeutic use
KW - Narcotic Antagonists/economics/therapeutic use
KW - Opiate Substitution Treatment/economics/methods
KW - opioid dependence
KW - Opioid-Related Disorders/drug therapy/economics/therapy
KW - Retrospective Studies
AU - A. Shah
AU - M. Duncan
AU - N. Atreja
AU - K. S. Tai
AU - M. Gore
A1 - 
BT - Journal of medical economics
C5 - Opioids & Substance Use; Financing & Sustainability
CP - 4
CY - England
DO - 10.1080/13696998.2018.1427101
IS - 4
JF - Journal of medical economics
PP - England
PY - 2018
SN - 1941-837X; 1369-6998
SP - 406
EP - 415
EP - 
T1 - Healthcare utilization and costs associated with treatment for opioid dependence
T2 - Journal of medical economics
TI - Healthcare utilization and costs associated with treatment for opioid dependence
U1 - Opioids & Substance Use; Financing & Sustainability
U2 - 29320915
U3 - 10.1080/13696998.2018.1427101
VL - 21
VO - 1941-837X; 1369-6998
Y1 - 2018
ER -